The FDA on Wednesday approved the industry’s first-ever tablet treatment for spinal muscular atrophy— Roche ’s SMN2 splicing ...

A Boston VC firm is launching a new neuroscience company with a $93M investment that aims to treat disorders including ...

Over the past nine years, patients with spinal muscular atrophy have seen the number of FDA-approved treatment options for ...

Drug manufacturer Novo Nordisk's amycretin, an experimental weight-loss pill in clinical trials, may boast substantial weight loss results comparable to those of popular GLP-1 injectables like Ozempic ...

Placebo pills help you stay on course by taking one daily until the next month. Skipping them can reduce or stop periods. You can speak to your doctor for more advice. Birth control pills are ...

GMRx2 was developed out of a 20-year research program at The George Institute for Global Health. The single pill is a combination of three best-in-class medicines: telmisartan, amlodipine and ...

Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google DeepMind CEO Demis Hassabis suggested Tuesday. Speaking on a panel at the World ...

The only judge based there is Matthew Kacsmaryk, a nominee of former President Donald Trump who previously ruled in favor of a challenge to the pill's approval. The states want the federal Food ...

A re­vived le­gal chal­lenge to the abor­tion pill mifepri­s­tone will be an ear­ly test for Pres­i­dent Don­ald Trump’s ad­min­is­tra­tion and his ap­petite for fur­ther weigh­ing ...

But it only worked when sleep was natural. Anesthesia and sleeping pills shut this process down nearly completely. The glymphatic system in the brain was discovered back in 2013 by Dr. Maiken ...

If anything, the gap understates the gulf between the soft-spoken, beetle-browed Hoffmann, who is the great-grandson of Fritz Hoffmann-La Roche, founder of pharmaceuticals group Roche, and the ...

Having made waves the world over, revolutionary anti-obesity drugs Wegovy and Ozempic (manufactured by Danish drugmaker Novo Nordisk), and Eli Lilly’s tirzepatide are set to enter the Indian ...